Founders Capital Management (Texas)’s Novavax NVAX Stock Holding History

Founders Capital Management (Texas)’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-500	Closed	-$3K	–	319
2019 Q3	$3K	Hold	500	–	–	﹤0.01%	308
2019 Q2	$3K	Hold	500	–	–	﹤0.01%	313
2019 Q1	$6K	Buy	500 +200	+67%	+$6.31K	0.01%	291
2018 Q4	$11K	Hold	300	–	–	0.01%	230
2018 Q3	$11K	Hold	300	–	–	0.01%	234
2018 Q2	$8K	Hold	300	–	–	0.01%	262
2018 Q1	$13K	Buy	300 +50	+20%	+$2.01K	0.01%	259
2017 Q4	$6K	Buy	250 +50	+25%	+$1.22K	0.01%	308
2017 Q3	$5K	Hold	200	–	–	﹤0.01%	322
2017 Q2	$5K	Buy	+200	New	+$3.92K	﹤0.01%	326

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Founders Capital Management (Texas)'s NVAX Position: Q4 2019 in Review

Founders Capital Management (Texas) sold out of Novavax (NVAX) in Q4 2019, closing a stake of 500 shares — an estimated $3K sold.

Founders Capital Management (Texas) first reported a position in NVAX in Q2 2017 and held it in 10 quarters. The position peaked at $13K in Q1 2018. 77 funds tracked by Wall St. Rank hold NVAX as of Q4 2019.

Founders Capital Management (Texas) reported no remaining Novavax position as of Q4 2019 after selling out during the quarter.
Founders Capital Management (Texas) sold 500 Novavax shares in Q4 2019, an estimated $3K.
Founders Capital Management (Texas) first reported a position in Novavax in Q2 2017 and held it in 10 quarters.
Founders Capital Management (Texas)'s Novavax position peaked at $13K in Q1 2018.
77 funds tracked by Wall St. Rank held Novavax as of Q4 2019.

Based on Founders Capital Management (Texas)'s 13F filing for Q4 2019, filed 24 Jan 2020.